The interaction of glucocorticoid (GC) and thyroxine (T4) in the generation of the hepatic enzyme overshoot and lipid response to starvation-refeeding was studied. Male Sprague-Dawley rats were either left intact, or treated with propylthiouracil (PTU), or adrenalectomized (ADX), or ADX and/or PTU treated and treated with GC and/or T4. One-half of each of these treatment groups was fed a 65% glucose diet while the remaining rats were starved for 48 hours and refed the glucose diet for 48 hours. After decapitation, hepatic lipid and glucose-6-phosphate dehydrogenase (G6PD) activity were determined. Rats treated with only PTU had less of an enzyme overshoot than nontreated rats, and the full overshoot response was re stored with T4 treatment. ADX rats did not have the typical enzyme overshoot re sponse to starvation-refeeding. However, ADX rats had their overshoot response restored with GC. PTU-treated ADX rats had more of an overshoot response than did ADX rats. When T4 was administered to PTU-treated ADX rats there was less of an enzyme overshoot; however, when both T4 and GC were administered to the PTUtreated ADX rats, the overshoot response was fully restored. The liver lipid response to starvation-refeeding followed a similar pattern except that in PTU-treated rats the liver lipid levels were significantly higher in the starved-refed rats than in the ad libitum-fed rats. These results indicate that T4 and GC play a role in the G6PD and liver lipid response to starvation-refeeding.
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starvation-refeeding â€¢thyroxine . glucocorti coid Starvation-refeeding is a technique wide-mized (ADX) rats have difficulty withstandly used to increase the hepatic lipogenic re-ing the starvation-refeeding treatment and sponse to dietary carbohydrate (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) . While fail to show the typical large increase in different investigators may use different G6PD activity and liver lipid at the end of time intervals, in our hands, this procedure the refeeding period (6) (7) (8) (9) (10) . Replacement of consists of a 48-hour starvation period fol-glucocorticoid in the ADX rat results in the lowed by a 48-hour period of refeeding a full development of the enzyme overshoot 65% glucose diet. The responses to this and liver lipid response to starvation-refeedtreatment typically include an increase in ing. The mechanisms of the involvement of the activity of glucose-6-phosphate de-glucocorticoid in the enzyme overshoot has hydrogenase (G6PD, EC 1.1.1.49), other been thought to be that of stimulating the NADP-linked enzymes, increased incorporade novo synthesis of the enzyme protein (7) . tion of 3HOH into fatty acids and an inThyroid hormone has also been shown to crease in liver lipid.
be involved in the responses to starvation, The magnitude of the lipogenic response depends largely on the presence of the Â® 1983 Amcrican institute Â°f Nutrition. Received forpublication is starvation-refeeding, and in the control of the activity of a variety of lipogenic enzymes (12-16) Hyperthyroid rats have been found to have fatty livers (14, 16) . Hypothyroid rats likewise have been found to have fatty livers (17) . These findings suggest that the thyroid hormones may be involved in the genesis of the fatty liver. Since rats given high doses of glucocorticoid and either fed ad libitum or periodically starved and refed do not be come fatty nor develop fatty livers (9, 18) , the question arises as to whether the thyroid hormones interact with the glucocorticoids such that they suppress the glucocorticoidinduced hyperlipogenic response to starva tion-refeeding. Thus, the present work was conducted to determine the respective roles of thyroid hormone and glucocorticoid in the generation of the liver lipid and enzyme overshoot response to starvation-refeeding.
MATERIALS AND METHODS
Animals. Male Sprague-Dawley rats (145 to 160 g initial weight, Sprague-Dawley, Madison, WI) were fed a commercial stock diet (Purina Laboratory Animal Chow, Ralston Purina Co., St. Louis, MO) for 3 days prior to use. The rats were housed in in dividual wire-mesh cages in a room con trolled for temperature (21 Â±1Â° ) and humidity (45-50%) with equal 12-hour periods of light and dark (lights on at 0600 hours). After acclimation, the rats were al located into 18 groups of six rats each. In some groups additional rats were used be cause of the expected mortality due to the treatments.
Treatments. Twelve groups of rats were anesthetized with intraperitoneal injections of sodium pentobarbital (3 mg/100 g body weight) and bilaterally ADX via a dorsal incision. Four days were allowed for re covery during which time they continued to gain weight. When they reached at least 200 g in weight the experiment commenced. During the recovery period, the ADX rats continued to be fed the stock diet. Their drinking water contained 0.9% NaCl. Twelve groups of rats were given daily propylthiouracil (PTU) injections (10 mg PTU/ 100 g body weight in 0.1 ml of 10% gum acacia, 6-N-propyl-2-thiouracil, Sigma Chemical Company, St. Louis, MO) subcutaneously. PTU injections were given 3 days prior to the starvation-refeeding treatment and continued until the end of the experi ment. PTU was used to suppress the produc tion of thyroid hormone by the thyroid gland (19) .
Intact, ADX, PTU and ADX-PTU rats were fed either ad libitum or not fed for 48 hours and refed for 48 hours a 65% glucose diet. This diet contained by weight the fol lowing ingredients: 1:1 casein:lactalbumin, 20%; glucose, 65%; corn oil, 5%, fiber (Alphacel, ICN Nutritional Biochemical Co., Cleveland, OH), 4%; Bernhardt-Tomarelli mineral mix (20), 4.9%; AOAC vita min mix (21), 1.1%. One-third of the ani mals, both ad libitum-fed and starved-refed were injected intraperitoneally twice daily with a sterile isotonic (0.9% NaCl) solution of cortisol (0.075 mg/100 g body weight, in jectable hydrocortisone sodium phosphate, Merck Co., Inc., West Point, PA). Cortisol was used rather than corticosterone, the most active glucocorticoid in the rat, be cause cortisol has a longer biological halflife than corticosterone. Also, one-third re ceived a single daily intraperitoneal injec tion of thyroxine (10 fig T4/100 g body weight) (DL-thyroxine, Sigma Chemical Co., St. Louis, MO). An outline of these treatments is presented in table 1.
Experimental. Body weights and food consumption were determined daily during the refeeding period. Animals were killed by decapitation. Livers were quickly excised, chilled, weighed and used for the deter mination of G6PD activity (22) . A 10% homogenate of the liver was prepared in icecold 0.14 M KC1 (pH 7.4) using a PotterElvehjem homogenizer (Wheaton Scientific, Millville, NJ). The homogenate was centrifuged (0 to 4Â°, 30 minutes, 20,000 x g) and the clear supernatant used, after the appro priate dilution with cold KC1 for the assay of G6PD activity. Lipid content was deter mined gravimetrically by extraction with a 2:2:1 ratio of chloroform, methanol and l M KC1, respectively. The means were com pared statistically by using the Student's itest for groups of unequal number (23) .
RESULTS
Consistent with the previous reports (1-9) starvation-refeeding resulted in the typical enzyme overshoot and increase in liver lipid in the intact rat (table 1) . Adrenalectomized rats fared less well with this treatment and did not greatly increase their enzyme activi ty nor were their liver lipid levels as high as their intact counterparts. The administra tion of glucocorticoid to ADX rats restored the overshoot and liver lipid responses to starvation-refeeding. These responses were consistent with those reported previously for ADX rats (6) (7) (8) (9) . Food intake, final body weight and liver weight were also affected by these treatments. Starvation-refeeding and ADX decreased final body weight. Ex cept in the ADX rats, liver weights were generally greater in the starved-refed rats than in the ad libitum-fed rats. Food intake was decreased in the starved-refed ADX rat. As has been previously discussed (6) (7) (8) (9) , the ADX rats do not readily resume feeding after the starvation period and some of these rats must be given a glucose solution by mouth before they will resume feeding. If not so "primed" their hypoglycemia worsens and they die (6) .
Treatment of the ad libitum-fed rat with PTU increased G6PD activity above that observed in the control rats (24.3 Â±4.0 vs. 13.6 Â±2.2), but liver lipid was significantly lower (3.92 Â±0.21 vs. 4.73 Â±0.07) than that of the control rats. The starvationrefeeding treatment of the PTU rats brought about an increase in both enzyme activity (35.2 Â±4.2 vs. 24.3 Â±4.0) and liver lipid (4.49 Â±0.14 vs. 3.92 Â±0.21). The increase in enzyme activity with starvation-refeed ing was not as great in the PTU-treated rats as in the control rats. Instead of a two-to threefold increase observed in the starvedrefed intact control rat (38.1 Â±3.2 vs. 13.6 Â±2.2), there was only a 50% increase (35.2 Â±4.2 vs. 24.3 Â±4.0). When T4 was ad ministered to PTU-treated ad libitum-fed rats, the enzyme activity, though lower, was not significantly different from the PTUtreated rats and was similar to that observed in the intact rats not treated with PTU. Liv er lipid in the T4-and PTU-treated rats was also similar to that of the intact ad libitumfed rats not treated with PTU. The same pattern was observed in the starved-refed rats: T4 administration reversed the PTU ef fects on the enzyme overshoot such that rats treated with both PTU and T4 responded to starvation-refeeding as did the control T4-treated rats without PTU. Food intake, final body weight and liver weight were all somewhat affected by PTU and T4. PTUtreated rats weighed less and had heavier livers than rats not treated with PTU. T4 treatment of the PTU-treated rats increased the food intake of these rats when starved and refed but not when ad libitum fed.
When the PTU and ADX treatments were combined, survival was limited. Only two of the six rats fed ad libitum and three of the six rats starved and refed survived. Because of this limited survival, comparison of these groups to the intact or the ADX or PTUtreated groups may be questionable. How ever, those that did survive weighed less than their counterparts in their respective control groups. They also consumed less food. Their liver weights were similar to those of the control intact and PTU-treated groups and more than those of the ADX groups. These animals had the typical en zyme overshoot but not the increase in liver lipid. When glucocorticoid was adminis tered to these ADX-and PTU-treated rats, survival rate improved. Five of the six rats in each of the dietary treatment groups sur vived. Food intake was increased with the restoration of this hormone as was liver weight, and the typical increase in enzyme activity and liver lipid was also observed.
When T4 was administered to these ADXand PTU-treated rats, survival was not im proved nor were there increases in body weight or food intake The starvation-re feeding treatment of these rats resulted in an enzyme overshoot but the liver lipid level was not increased. In fact, it was decreased compared to the ad libitum-fed rats sub jected to the same treatments.
Lastly, when both hormones were re stored to the ADX-and PTU-treated rats, final body weight and food intake were similar to those of the intact, untreated rats. In addition, the means for liver weight, enzyme activity and liver lipid of the starved-refed rats of these treatments far surpassed those of the intact untreated starved-refed control rats.
DISCUSSION
In a previous work (9, 18) we reported that rats given high doses of glucocorticoid and/or either fed ad libitum or periodically starved and refed did not develop fatty liv ers. Since ADX-and GC-treated starvedrefed rats do develop fatty livers, the ques tion arises as to the mechanisms involved, which would explain why the latter treat ment results in a fatty liver but the former does not. We hypothesized that the thyroid hormones may be involved. While the re sults of the present work demonstrate that both glucocorticoid and thyroid hormone are involved in the development of the in crease in liver lipid in response to starvationrefeeding, there does not appear to be any interaction between the two. In view of the differential responses of enzyme activity and liver lipid to these two hormones, it is possible that these hormones function sep arately within the starve-refeed response and that there is no reason to suggest a regulatory function of the one on the other. Glucocorticoid influenced both the enzyme overshoot and the liver lipid. In the absence of thyroid hormone, or, as in this study, in the PTU-treated ADX rat, glucocorticoid re placement restored the enzyme overshoot but did not have any effect on liver lipid. In contrast, thyroid hormone administered to the PTU-treated ADX rat resulted in a small enzyme overshoot and little or no increase in liver lipid. When both hormones were re placed, both enzyme overshoot and liver lipid responses were restored.
Although there is usually a good correla tion between the activity of G6PD and liver lipid (24) , the results of the present work would suggest that this may be circumstan tial. It appears that the induction of the en zyme overshoot via de novo enzyme protein synthesis may have been due to the action of both hormones on this process. Thyroid hor mone has been shown to stimulate protein synthesis (25) (26) (27) . Since treatment with PTU inhibits thyroid hormone production, the modest increase in G6PD activity in the starved-refed PTU-treated rat may have been due to a substrate-induced increase in enzyme activity and/or to limited de novo enzyme protein synthesis possible through residual thyroid hormone activity assuming that the dose of PTU used did not complete ly block thyroid hormone production. PTU treatment without starvation-refeeding also increased G6PD activity above that of the untreated ad libitum-fed control group, but this increase was probably not diet depen dent since the PTU treatment was initiated prior to any dietary change. Perhaps, the in crease in G6PD activity was due to an effect of PTU on thyroid-stimulating hormone (TSH) secretion. PTU, as an inhibitor of thy roid hormone synthesis and release, results in lower serum T3 and T4 levels. These de creases would signal the pituitary to pro duce TSH and this TSH in turn may have stimulated the pentose shunt seen as an in crease in G6PD activity without an increase in liver lipid in the ad libitum-fed rats.
The decrease in liver lipid in PTU-treated rats likely was due to a decreased hepatic lipogenesis together with a decreased pe ripheral lipolysis and transport of lipids to the liver. A decreased lipid turnover, par ticularly in the ad libitum-fed rat, could ac count for this observation. The liver lipid levels were restored when T4 was injected thus showing a direct effect of thyroid hor mone status on liver lipid levels, an effect that was potentiated by the starvation-re feeding treatment.
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